PI3K Signaling Pathway Abnormalities in Two Patients with PIK3CD (p110δ) Loss-of-Function (LOF) Variants
Alexander Vargas-Hernández, Kejian Zhang, Lalith Perera, Michail S. Lionakis et autres
0 citationsJournal of Human Immunity
Michael B. Jordan
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
324Publications signalées
18019Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Autoimmune and Inflammatory Disorders ResearchImmune Cell Function and InteractionImmunodeficiency and Autoimmune DisordersParvovirus B19 Infection StudiesHematopoietic Stem Cell Transplantation
Publications récentes
Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment
Bethany Verkamp, Michael B. Jordan, Carl E. Allen
6 citationsBlood
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study
Adi Zoref‐Lorenz, Carl E. Allen, Edward M. Behrens, Shanmuganathan Chandrakasan et autres
6 citationsBlood Advances
Patient journey to Fabry disease diagnosis in the United States: an observational retrospective analysis of two United States claims databases
Alexandra Dumitriu, Gandarvaka Miles, Ana Maria Viegas-Crespo, И. А. Максимова et autres
0 citationsOrphanet Journal of Rare Diseases
Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders
Sharat Chandra, Kenneth D. Greis, Somchai Chutipongtanate, Nathan Luebbering et autres
1 citationBlood Advances
Emapalumab induces rapid, durable responses and reliable bridging to curative HSCT in patients with primary HLH: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09
Michael B. Jordan, Franco Locatelli, Didier Halimi, Elena Burillo et autres
1 citationBlood
Use of emapalumab is associated with rapid and sustained benefits in primary HLH subgroups, including CNS involvement and previously untreated patients: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09
Franco Locatelli, Michael B. Jordan, Didier Halimi, Elena Burillo et autres
0 citationsBlood
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Kaja Abbas et autres
0 citationsThe Lancet Infectious Diseases
122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS
Adi Zoref‐Lorenz, Elliot Cahn, Eric Mou, George Cholack et autres
0 citationsHematological Oncology
The optimized HLH inflammatory index: A novel prognostic tool for newly diagnosed patients with diffuse large B-cell lymphoma—Discovery and validation.
Adi Zoref Lorenz, Elliot Cahn, Eric Mou, Yucai Wang et autres
0 citationsJournal of Clinical Oncology
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
11 citationsThe Lancet Infectious Diseases
Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary
Shanmuganathan Chandrakasan, Carl E. Allen, Deepika Bhatla, John Carter et autres
0 citationsImmunotherapy
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.